These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1923396)

  • 1. Determining therapeutic efficacy in recurrent herpes labialis by lesion size analysis.
    Rodu B; Russell CM; Mattingly G
    Oral Surg Oral Med Oral Pathol; 1991 Aug; 72(2):178-83. PubMed ID: 1923396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
    Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
    Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.
    Kaminester LH; Pariser RJ; Pariser DM; Weiss JS; Shavin JS; Landsman L; Haines HG; Osborne DW
    J Am Acad Dermatol; 1999 Dec; 41(6):996-1001. PubMed ID: 10570387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
    Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
    Busch R; Graubaum HJ; Gruenwald J; Faergemann J
    Adv Ther; 2009 Jul; 26(7):719-27. PubMed ID: 19649583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.
    Kawashima M; Watanabe D; Fujio K; Komazaki H
    J Dermatol; 2023 Mar; 50(3):311-318. PubMed ID: 36353762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
    Koytchev R; Alken RG; Dundarov S
    Phytomedicine; 1999 Oct; 6(4):225-30. PubMed ID: 10589440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
    Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
    J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study.
    Spruance SL; McKeough MB
    J Infect Dis; 2000 Jun; 181(6):1906-10. PubMed ID: 10837169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis.
    Spruance SL; Crumpacker CS; Haines H; Bader C; Mehr K; MacCalman J; Schnipper LE; Klauber MR; Overall JC
    N Engl J Med; 1979 May; 300(21):1180-4. PubMed ID: 86158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis.
    Skulason S; Holbrook WP; Thormar H; Gunnarsson GB; Kristmundsdottir T
    J Oral Pathol Med; 2012 Jan; 41(1):61-7. PubMed ID: 21535163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit.
    Spruance SL; Crumpacker CS
    Am J Med; 1982 Jul; 73(1A):315-9. PubMed ID: 6285721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical ether and herpes simplex labialis.
    Guinan ME; MacCalman J; Kern ER; Overall JC; Spruance SL
    JAMA; 1980 Mar; 243(10):1059-61. PubMed ID: 6243714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double-blind, dose-ranging, placebo-controlled, multicenter trial.
    Spruance SL; Rowe NH; Raborn GW; Thibodeau EA; D'Ambrosio JA; Bernstein DI
    J Infect Dis; 1999 Feb; 179(2):303-10. PubMed ID: 9878012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.